Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS
Ahmed Magdi Omar/LinkedIn
Apr 14, 2026, 16:49

Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS

Ahmed Magdi Omar, Cardiologist at MantraCare, Cardiovascular Specialist at Damas GIT and Cardio-vascular Center, shared a post on LinkedIn:

“Antiplatelet Therapy in Acute Ischemic Stroke (AIS)

From the Latest 2026 Guidelines

8 Key Takeaways

1. Dual Antiplatelet Therapy (DAPT)

(For non-cardioembolic patients Not eligible for revascularization)

Within <24 hours of symptom onset

  • Aspirin and Clopidogrel for 21 days, then single antiplatelet therapy (SAPT)

Indications:

  • Minor AIS (NIHSS ≤3) or high-risk TIA (ABCD2 ≥4) (Class 1)
  • NIHSS 4–5 with presumed atherosclerotic cause (≥50% stenosis or imaging evidence) (Class 2a)

Aspirin and Ticagrelor for 30 days

Indications:

  • Minor AIS (NIHSS ≤5) or high-risk TIA (ABCD2 ≥6 or ≥50% symptomatic stenosis) (Class 2b)

24–72 hours after symptom onset

Aspirin and Clopidogrel for 21 days, then SAPT

Indications:

  • Minor AIS (NIHSS ≤5) or high-risk TIA (ABCD2 ≥4)
  • With presumed atherosclerotic cause (Class 2a)

2. Aspirin Timing

  • Start within 48 hours after stroke onset (Class 1)

3. Triple Antiplatelet Therapy

  • Not recommended (Aspirin and Clopidogrel and Dipyridamole)
  • Due to increased bleeding risk (Class 3: Harm)

4. Stroke Occurring While on Aspirin

  • Increasing aspirin dose or switching antiplatelet
  • No clear benefit (Class 2b)

5. Ticagrelor vs Aspirin

  • In minor AIS (NIHSS ≤3) or high-risk TIA (ABCD2 ≥4)
  • Ticagrelor is not superior to aspirin (Class 3: No benefit)

6. Stroke with Atrial Fibrillation on Anticoagulation

  • Do NOT routinely add antiplatelet
  • Increased bleeding risk (Class 3: Harm)

7. Antiplatelet Within 24 Hours After IV Thrombolysis (IVT)

  • Risk is uncertain
  • May consider in selected cases with strong indication (Class 2b)

8. Patients on Antiplatelet Who Need IV Thrombolysis

  • Still recommend IVT
  • Improves functional outcomes
  • Benefit outweighs increased intracranial hemorrhage risk (Class 1).

Reference

2026 AHA/ASA Guideline for the Early Management of Acute Ischemic Stroke (January 27, 2026).”

Stay updated with Hemostasis Today.

acute ischemic stroke Ahmed Magdi Omar AIS Aspirin Atrial Fibrillation clopidogrel DAPT Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine stroke thrombosis
NewsFeed